These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 5188463

  • 1. The prognosis of pulmonary tuberculosis in Finland.
    Lahesmaa R.
    Scand J Respir Dis Suppl; 1968; 63():37-44. PubMed ID: 5188463
    [No Abstract] [Full Text] [Related]

  • 2. The frequency of postpleuritic tuberculosis.
    Heinivaara O, Lindeberg L, Pätiälä J.
    Scand J Respir Dis Suppl; 1970; 72():42-4. PubMed ID: 5273218
    [No Abstract] [Full Text] [Related]

  • 3. [Possibilities of resolving cases of chronic pulmonary tuberculosis].
    Mihăilescu P, Plopeanu D, Fonea M, Damian N, Amzărescu E, Mardale C, Moldovan L, Molniceanu I, Zavate T, Baciu A.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(3):205-14. PubMed ID: 6318293
    [No Abstract] [Full Text] [Related]

  • 4. Medical and social aspects of chronic pulmonary tuberculosis in Finland.
    Tani P.
    Scand J Respir Dis Suppl; 1970; 72():93-105. PubMed ID: 5273228
    [No Abstract] [Full Text] [Related]

  • 5. Pulmonary tuberculosis and diabetes mellitus.
    Perret L.
    Scand J Respir Dis Suppl; 1970; 72():68-71. PubMed ID: 5273224
    [No Abstract] [Full Text] [Related]

  • 6. [The results of long-term follow-up of pulmonary tuberculosis patients found by the tuberculosis prevalence surveys. IV. Prognosis of pulmonary tuberculosis evaluated by the survival rate and the mortality rate].
    Kihara K.
    Kekkaku; 1972 Feb; 47(2):51-7. PubMed ID: 5049127
    [No Abstract] [Full Text] [Related]

  • 7. [Sociomedical factors influencing mortality in patients with tuberculosis].
    Frolova IA.
    Probl Tuberk Bolezn Legk; 2004 Feb; (3):10-3. PubMed ID: 15338891
    [Abstract] [Full Text] [Related]

  • 8. The prognosis for different categories of tuberculosis patients.
    Iversen E.
    Scand J Respir Dis Suppl; 1970 Feb; 72():61-6. PubMed ID: 5273222
    [No Abstract] [Full Text] [Related]

  • 9. [Causes of ineffective treatment of newly detected pulmonary tuberculosis].
    Borshtenbinder IV, Smirnov GA.
    Probl Tuberk; 1978 Oct; (10):33-6. PubMed ID: 714904
    [No Abstract] [Full Text] [Related]

  • 10. [Early and late results of 6-month treatment of pulmonary tuberculosis with various drug combinations].
    Rogowski J, Zierski M, Bek E, Snider DE, Long MW.
    Pneumonol Pol; 1982 Sep; 50(9):425-35. PubMed ID: 7163000
    [No Abstract] [Full Text] [Related]

  • 11. [Effectiveness of short-term chemotherapy in patients with newly detected destructive pulmonary tuberculosis].
    Gol'dshtein VD, Komissarenko IB, Churilova RI, Kulik EI, Niamtsu EA.
    Probl Tuberk; 1984 Jan; (1):29-34. PubMed ID: 6701168
    [No Abstract] [Full Text] [Related]

  • 12. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML, Iuditskiĭ MV, Semenova OV.
    Probl Tuberk Bolezn Legk; 2004 Jan; (3):26-8. PubMed ID: 15338896
    [Abstract] [Full Text] [Related]

  • 13. The prognosis of bacillary pulmonary tuberculosis with modern treatment.
    Hillerdal O.
    Scand J Respir Dis Suppl; 1968 Jan; 63():33-6. PubMed ID: 5188462
    [No Abstract] [Full Text] [Related]

  • 14. [Ambulant primary treatment of pulmonary tuberculosis: retrospective analysis of 109 cases followed-up for seven years (author's transl)].
    Hu PY.
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Dec; 3(4):219-20. PubMed ID: 7297338
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of pulmonary tuberculosis: state of the art, 1978.
    Anderson HR.
    J Tenn Med Assoc; 1978 Sep; 71(9):647-50. PubMed ID: 703307
    [No Abstract] [Full Text] [Related]

  • 16. Factors associated with deaths among pulmonary tuberculosis patients: a case-control study with secondary data.
    Duarte EC, Bierrenbach AL, Barbosa da Silva J, Tauil PL, de Fátima Duarte E.
    J Epidemiol Community Health; 2009 Mar; 63(3):233-8. PubMed ID: 19066188
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of differences in the course of pulmonary tuberculosis 1959-60 and 1979-82].
    Madey B, Strzałkowska D, Mierzejewska A.
    Wiad Lek; 1986 Mar 01; 39(5):289-93. PubMed ID: 3727559
    [No Abstract] [Full Text] [Related]

  • 18. Studies on the prognosis of cases with open negative cavity developing mainly due to therapy with primary antituberculosis drugs.
    Fujioka K, Yoshida F, Kawamoto H, Takahashi O, Nishiyama K, Hidaka O.
    Jpn J Tuberc; 1966 Dec 01; 13():Suppl:65-70. PubMed ID: 5298481
    [No Abstract] [Full Text] [Related]

  • 19. [Results of treatment of pulmonary tuberculosis with drug aerosols].
    Magaletskiĭ IF.
    Vrach Delo; 1978 Feb 01; (2):20-3. PubMed ID: 644992
    [No Abstract] [Full Text] [Related]

  • 20. Serum hexosamine, iron, and total iron-binding capacity during drug treatment of pulmonary tuberculosis.
    Tani P, Kokkola K.
    Scand J Respir Dis Suppl; 1972 Feb 01; 80():143-51. PubMed ID: 4510911
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.